HDAC inhibition impedes epithelial-mesenchymal plasticity and suppresses metastatic, castration-resistant prostate cancer.
about
Cancer stem cell heterogeneity: origin and new perspectives on CSC targetingExploiting Epigenetic Alterations in Prostate Cancer.Epithelial/mesenchymal plasticity: how have quantitative mathematical models helped improve our understanding?Gene signature associated with benign neurofibroma transformation to malignant peripheral nerve sheath tumorsValproic acid inhibits irradiation-induced epithelial-mesenchymal transition and stem cell-like characteristics in esophageal squamous cell carcinoma.Marine-derived chromopeptide A, a novel class I HDAC inhibitor, suppresses human prostate cancer cell proliferation and migration.Cellular determinants and microenvironmental regulation of prostate cancer metastasis.Entinostat: a promising treatment option for patients with advanced breast cancer.Roles and epigenetic regulation of epithelial-mesenchymal transition and its transcription factors in cancer initiation and progression.Phosphorylation-induced conformational dynamics in an intrinsically disordered protein and potential role in phenotypic heterogeneity.Strategies to avoid treatment-induced lineage crisis in advanced prostate cancer.Next-generation sequencing survey of biliary tract cancer reveals the association between tumor somatic variants and chemotherapy resistance.Epithelial plasticity and metastatic cascade.Withaferin A Inhibits Prostate Carcinogenesis in a PTEN-deficient Mouse Model of Prostate Cancer.Epigenetic Regulation in Prostate Cancer Progression.PARP inhibitor veliparib and HDAC inhibitor SAHA synergistically co-target the UHRF1/BRCA1 DNA damage repair complex in prostate cancer cellsEnvironmentally Induced Alterations in the Epigenome Affecting Obesity and Cancer in Minority PopulationsCotargeting the Cell-Intrinsic and Microenvironment Pathways of Prostate Cancer by PI3Kα/β/δ Inhibitor BAY1082439Dynamism, Sensitivity, and Consequences of Mesenchymal and Stem-Like Phenotype of Cancer CellsHDAC Inhibition Counteracts Metastatic Re-Activation of Prostate Cancer Cells Induced by Chronic mTOR Suppression
P2860
Q33649230-3D062F66-06B8-4D25-8EAF-6DE7EEB48491Q33755160-A6AB5223-44BE-483E-A725-E347C67263C0Q33869760-D406ECAA-45AA-443E-8ECC-EB73599D644EQ36380337-9D399C5F-EC6F-4364-98C9-E3106DB975E6Q37337989-1137D714-0340-4D3B-8022-456CC33CA334Q37744742-2A831BF9-3A0E-44A1-BE4B-37B7BAB9E9B8Q38730590-2719377F-255C-4968-A72B-D066666DE92BQ38741783-66AD16BA-0CEA-47C5-A267-620837EB8152Q38909048-9267035B-9D01-490D-8EE1-D40F25D385BFQ38910392-6A2C8552-560B-48CF-960E-9EF6BFBF6E39Q39016544-B2E96A7F-A13D-4578-BCF0-A7EB433ECF26Q40633762-299DC3DD-67A7-4016-B986-3686EE837827Q49714352-33654D12-B590-475C-879A-14CE926AF8E8Q52870570-89E29281-D9B9-4442-8F23-90C5F3D0B12AQ54974720-22557965-8A6F-49EB-90B5-0389BE5BDA1AQ57175832-2F421889-21F1-4DD0-BC40-8744CF73BE99Q57433696-AFF5F0C0-5F83-478C-AD0E-B71D84A1E9E5Q57449225-0CE42AB3-7520-4720-A87B-8E32E0BA97F5Q58577525-30BB7745-A6A5-44FE-9F48-7A3D0A6923CAQ58773654-48D74D80-6AD5-4F1C-B4E1-126A3852DE83
P2860
HDAC inhibition impedes epithelial-mesenchymal plasticity and suppresses metastatic, castration-resistant prostate cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
HDAC inhibition impedes epithe ...... ion-resistant prostate cancer.
@en
type
label
HDAC inhibition impedes epithe ...... ion-resistant prostate cancer.
@en
prefLabel
HDAC inhibition impedes epithe ...... ion-resistant prostate cancer.
@en
P2093
P2860
P356
P1433
P1476
HDAC inhibition impedes epithe ...... tion-resistant prostate cancer
@en
P2093
D Bianchi-Frias
D J Mulholland
E L Dadashian
N Kobayashi
P S Nelson
P2860
P2888
P304
P356
10.1038/ONC.2015.444
P407
P577
2015-12-07T00:00:00Z